mazindol has been researched along with Depression in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McMahon, LR | 1 |
| Cunningham, KA | 1 |
| Bruera, E | 1 |
| Carraro, S | 1 |
| Roca, E | 1 |
| Barugel, M | 1 |
| Chacon, R | 1 |
1 trial available for mazindol and Depression
| Article | Year |
|---|---|
Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
Topics: Anxiety; Appetite; Clinical Trials as Topic; Depression; Female; Humans; Indoles; Male; Mazindol; Mi | 1986 |
1 other study available for mazindol and Depression
| Article | Year |
|---|---|
Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Catecholamines; Depression; D | 2001 |